Literature DB >> 33414459

Deletion of IKK2 in haematopoietic cells of adult mice leads to elevated interleukin-6, neutrophilia and fatal gastrointestinal inflammation.

Karla C Fischer1,2,3, Carmel P Daunt4, Cédric S Tremblay4, Sheila Dias5, James E Vince5,6, Anissa M Jabbour4.   

Abstract

The IκB kinase complex, consisting of IKK1, IKK2 and the regulatory subunit NEMO, is required for NF-κB signalling following the activation of several cell surface receptors, such as members of the Tumour Necrosis Factor Receptor superfamily and the Interleukin-1 Receptor. This is critical for haematopoietic cell proliferation, differentiation, survival and immune responses. To determine the role of IKK in the regulation of haematopoiesis, we used the Rosa26Cre-ERT2 Cre/lox recombination system to achieve targeted, haematopoietic cell-restricted deletion of the genes for IKK1 or IKK2 in vivo. We found that the IKK complex plays a critical role in haematopoietic cell development and function. Deletion of IKK2, but not loss of IKK1, in haematopoietic cells led to an expansion of CD11b/Gr-1-positive myeloid cells (neutrophilia), severe anaemia and thrombocytosis, with reduced numbers of long-term haematopoietic stem cells (LT-HSCs), short-term haematopoietic stem cells (ST-HSCs) and multipotential progenitor cells (MPPs), increased circulating interleukin-6 (IL-6) and severe gastrointestinal inflammation. These findings identify distinct functions for the two IKK catalytic subunits, IKK1 and IKK2, in the haematopoietic system.

Entities:  

Year:  2021        PMID: 33414459      PMCID: PMC7791118          DOI: 10.1038/s41419-020-03298-9

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  74 in total

1.  The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis.

Authors:  Kiran Assi; Rex Pillai; Antonio Gómez-Muñoz; David Owen; Baljinder Salh
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Integrating cell-signalling pathways with NF-kappaB and IKK function.

Authors:  Neil D Perkins
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

Review 3.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Authors:  Gary L Johnson; Kazuhiro Nakamura
Journal:  Biochim Biophys Acta       Date:  2007-01-04

Review 4.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

6.  IKK beta is required for peripheral B cell survival and proliferation.

Authors:  Zhi-Wei Li; Sidne A Omori; Tord Labuda; Michael Karin; Robert C Rickert
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

7.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

Authors:  C Makris; V L Godfrey; G Krähn-Senftleben; T Takahashi; J L Roberts; T Schwarz; L Feng; R S Johnson; M Karin
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

Review 8.  Normocytic anemia.

Authors:  J R Brill; D J Baumgardner
Journal:  Am Fam Physician       Date:  2000-11-15       Impact factor: 3.292

9.  The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4.

Authors:  Li-Chung Hsu; Jin Mo Park; Kezhong Zhang; Jun-Li Luo; Shin Maeda; Randal J Kaufman; Lars Eckmann; Donald G Guiney; Michael Karin
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

Review 10.  Role of the JNK signal transduction pathway in inflammatory bowel disease.

Authors:  Praveen K Roy; Farzana Rashid; Jack Bragg; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.